The Lancet on X: "3/4 of #COVID19 trials reviewed specifically excluded expectant mothers, even though they were investigating medications and vitamins that already have a relatively favourable safety profile during pregnancy, or
Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats - eBioMedicine
Frontiers | Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020 | MMWR
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - ScienceDirect
Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19? | BMC Pregnancy and Childbirth
Safety categories of potential COVID-19 drugs during pregnancy and... | Download Scientific Diagram
The Incidence, Severity, and Management of COVID-19 in Critically Ill Pregnant Individuals - Ontario COVID-19 Science Advisory Table
Efficacy and safety of monoclonal antibodies against SARS-CoV-2 during pregnancy
SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review - ScienceDirect
Processes | Free Full-Text | COVID-19-Current Therapeutical Approaches and Future Perspectives
A medication-wide association study (MWAS) on repurposed drugs for COVID-19 with Pre-pandemic prescription medication exposure and pregnancy outcomes | Scientific Reports
Viruses | Free Full-Text | Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
Remdesivir in pregnant women with moderate to severe coronavirus disease 2019 (COVID-19): a retrospective cohort study | Clinical and Experimental Medicine
Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19? | BMC Pregnancy and Childbirth
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 | ACS Central Science
Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats - eBioMedicine
Frontiers | Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials
The Incidence, Severity, and Management of COVID-19 in Critically Ill Pregnant Individuals - Ontario COVID-19 Science Advisory Table
Pregnancy and COVID-19 | Physiological Reviews
Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report - Alavi - 2022 - Clinical Case Reports - Wiley Online Library
Remdesivir | COVID-19 Treatment Guidelines
Frontiers | Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (
Safety of Medications During Pregnancy - Women's Health Issues - MSD Manual Consumer Version
Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems | CIDRAP
Call for a unified approach to Monkeypox infection in pregnancy: Lessons from the COVID-19 pandemic | Nature Communications
Remdesivir (Veklury) for COVID-19 | The Medical Letter Inc.
